• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN MEDICAL SAS CELSITE; ACCESS PORT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN MEDICAL SAS CELSITE; ACCESS PORT SYSTEM Back to Search Results
Model Number 4430395
Device Problem Expulsion (2933)
Patient Problems Bacterial Infection (1735); Purulent Discharge (1812)
Event Date 03/11/2024
Event Type  Injury  
Manufacturer Narrative
Note: product reference (b)(4) is not cleared for sales in the usa, but it is similar to a product reference cleared under.#510k130576.Batch history review: batch unknown.Investigation results: the device was not returned for evaluation.No picture of the event was supplied.No thorough investigation is possible.Conclusion: the access port exteriorization is a known complication of access port implantation.Without any element for investigation it is not possible to determine the root cause of this event.The raw material used, the manufacturing, cleaning and sterilization processes have not changed in recent months/years.There is no increasing trend in the reporting of such event.The main documented root causes of exteriorisation are: - allergy, infection, important patient weight loose.- the fact that the access port housing was implanted just under the skin incision, not at one centimeter of the skin incision as recommended.The ifu specifies: vi-1-1 k) "confirm catheter patency (by ensuring that both aspiration and injection are possible), ensure that the skin incision is 1 cm from the injection site." - the fact that the access port was implanted too superficially: the ifu specifies: vi-1-1 "f) prepare the port pocket at the chosen site, the port should lie approximately 1/2 - 1 cm below the skin surface away from the injection site." - poor maintenance this is a rare incident, no corrective action is envisaged.
 
Event Description
Patient with dehiscence of implantable catheter wound, with scarce seropurulent secretion, without signs of cellulitis, denies fever, denies bleeding, denies other symptoms.The infusion of 4 fu is deferred, the rest of the scheme is started by peripheral vein, it is discussed with the treating oncologist and coordinator, it is defined to prioritize catheter change in the course of the week, antibiotic coverage is indicated according to specialist recommendations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELSITE
Type of Device
ACCESS PORT SYSTEM
Manufacturer (Section D)
B.BRAUN MEDICAL SAS
26 rue armengaud
saint cloud, 92210
FR  92210
Manufacturer (Section G)
B.BRAUN MEDICAL SAS FRANCE
30 avenue des temps modernes
chasseneuil du poitou 86360
FR   86360
Manufacturer Contact
catherine boismenu
30 avenue des temps modernes
chasseneuil du poitou 86360
FR   86360
MDR Report Key19141760
MDR Text Key340567088
Report Number9612452-2024-00014
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Reporter Country CodeCO
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number4430395
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/19/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age41 YR
Patient SexFemale
-
-